Literature DB >> 8893048

Covariability of V3 loop amino acids.

P J Bickel1, P C Cosman, R A Olshen, P C Spector, A G Rodrigo, J I Mullins.   

Abstract

We reanalyzed for covariability a set of 308 human immunodeficiency virus type 1 (HIV-1) V3 loop amino acid sequences from the B envelope sequence subtype previously analyzed by Korber et al.,1 as well as a new set of 440 sequences that also included substantial numbers of sequences from subtypes A, D, and E. We used the measure employed by Korber et al., essentially the likelihood ratio statistic for independence, plus two additional measures as well as clade information to examine the new set and both data sets simultaneously. We set forth the following conclusions and observations. The eight most highly connected sites identified through these statistical approaches included all of the six residues previously shown to have determining roles in structure, immunologic recognition, virus phenotype, and host range; each of the seven pairs of covariant sites found by Korber were signaled by our additional two measures in the set of 308 sequences, although 2 or 3 dropped out of the examination of the set of 440 when the requirement of stringent significance was applied for some or all of the three tests, respectively; using the same criteria, a total of 20 (including 5 Korber et al. pairs) or a total of 6 (including 4 Korber et al. pairs) were found when the set of 440 was added. Several limitations to statistical analysis of this type of HIV sequence data were also noted. For example, the data sets were, by historical necessity, collected haphazardly. For example, it was not possible to separate substantially sized groups out according to time of or since infection, disease status, antiviral treatment, geography, etc. There was also an enormous "wealth of significance" within the data. For example, for one measure the 440 data set showed 233 of the 465 pairs of sites with a likelihood ratio statistic of < 0.001. Last, most sites had consensus amino acids in 80% or more of the sequences; hence, there was an absence of data on many combinations of amino acids. Given the observed linkage between sites shown to be covariable and those known to have critical biological function, the statistical approaches we and Korber et al. have outlined may find use in predicting critical structural features of HIV proteins as targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893048     DOI: 10.1089/aid.1996.12.1401

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Finding important sites in protein sequences.

Authors:  Peter J Bickel; Katherina J Kechris; Philip C Spector; Gary J Wedemayer; Alexander N Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

2.  Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins.

Authors:  Milloni B Patel; Noah G Hoffman; Ronald Swanstrom
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

3.  Coordinate linkage of HIV evolution reveals regions of immunological vulnerability.

Authors:  Vincent Dahirel; Karthik Shekhar; Florencia Pereyra; Toshiyuki Miura; Mikita Artyomov; Shiv Talsania; Todd M Allen; Marcus Altfeld; Mary Carrington; Darrell J Irvine; Bruce D Walker; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

4.  Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop.

Authors:  Noah G Hoffman; Francoise Seillier-Moiseiwitsch; JaeHyung Ahn; Jason M Walker; Ronald Swanstrom
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Authors:  V Novitsky; U R Smith; P Gilbert; M F McLane; P Chigwedere; C Williamson; T Ndung'u; I Klein; S Y Chang; T Peter; I Thior; B T Foley; S Gaolekwe; N Rybak; S Gaseitsiwe; F Vannberg; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region.

Authors:  Jack da Silva; Mia Coetzer; Rebecca Nedellec; Cristina Pastore; Donald E Mosier
Journal:  Genetics       Date:  2010-02-15       Impact factor: 4.562

7.  Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor.

Authors:  Sarah K Ho; Elena E Perez; Stephanie L Rose; Roxana M Coman; Amanda C Lowe; Wei Hou; Changxing Ma; Robert M Lawrence; Ben M Dunn; John W Sleasman; Maureen M Goodenow
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

8.  Amino acid covariation in a functionally important human immunodeficiency virus type 1 protein region is associated with population subdivision.

Authors:  Jack da Silva
Journal:  Genetics       Date:  2009-03-11       Impact factor: 4.562

9.  The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms.

Authors:  Hayley Crawford; Philippa C Matthews; Malinda Schaefer; Jonathan M Carlson; Alasdair Leslie; William Kilembe; Susan Allen; Thumbi Ndung'u; David Heckerman; Eric Hunter; Philip J R Goulder
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

10.  A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.

Authors:  Alexander G Holman; Dana Gabuzda
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.